2Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide- resistant Myeoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro[ J]. Microbiol lmmunol,2001,45 (8) : 617 -620.
3Xin D, Mi Z, Han X, et al. Molecular mechanisms of maerolide resistance in clinical isolates of myeoplasma pneumoniae from China [ J ]. Antimicrob Agents Chemother ,2009 ,5 3 ( 5 ) :2158 -2159.
4Dumke R, yon Baum H, Ltick PC, et al. Occurrence of macrolide -resistant Mycoplasma pneumoniae strains in Germany[ J]. Clin Microbiol Infect,2010,16(6) :613 -616.
5Peuchant O, Menard A, Renaudin H, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real - time PCR and melting curve analysis [ J ]. J Antimicrob Chemother,2009,64( 1 ) :52 -58.
6Morozumi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community - acquired pneumonia [ J ]. Antimicrob Agents Chemother, 2008,52 ( 1 ) : 348 - 350.
7Cao B,Zhao CJ,Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China [ J ]. Clin Infect Dis, 2010,51 (2) :189 -194.
8Morozumi M, Takahashi T, Ubukata K. Macrolide -resistant Mycoplasma pneumoniae:Characteristics of isolates and clinical aspects of com- munity - acquired pneumonia [ J ]. J Infect Chemother, 2010,16 ( 2 ) : 78 - 86.
9Matsubara K, Morozunfi M, Okada T,et al. A eomparative clinical study of maerolide - sensitive and macrolide - resistant Mycoplasma pneumoniae infeetions in pediatric patients [ J ]. J Infect Chemother,2009 ,15 (6) :380 -383.
10Baer G,Engeicke G, Abele - Horn M, et al. Role of chlamydia pneumoniae and mycoplasma pneumoniae as causative agents of community- acquired pneumonia in hospitalised children and adolescents [ J]. Eur J Clin Microbiol Infect Dis ,2003,22 ( 12 ) :742 - 745.
